Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of a New BI-specifiC Antibody Towards Dendritic Cells on Inflammation in Rheumatoid Arthritis

NCT03416543 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT03416543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03416543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of a New BI-specifiC Antibody Towards Dendritic Cells on Inflammation in Rheumatoid Arthritis
Lead sponsor
University Hospital, Tours
Phase
Observational
Overall status
Completed
Start date
December 13, 2017
Completion date
December 8, 2021
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gout, osteoarthritis, rheumatoid arthritis